journal article·2023-12-19Open access

Cryo-TEM Reveals the Influence of Multivalent Charge and PEGylation on Shape Transitions in Fluid Lipid Assemblies: From Vesicles to Discs, Rods, and Spheres

Victoria M. Steffes, Zhening Zhang, Kai K. Ewert, Cyrus R. Safinya

Langmuir· Volume 39· Issue 50

Abstract

Lipids, and cationic lipids in particular are of interest as delivery vectors for hydrophobic drugs such as the cancer therapeutic paclitaxel, and the structures of lipid assemblies affect their efficacy. We investigated the effect of incorporating the multivalent cationic lipid MVL5 (+5 e ) and poly(ethylene glycol)-lipids (PEG-lipids), alone and in combination, on the structure of fluid-phase lipid assemblies of the charge-neutral lipid 1,2-dioleoyl- sn -glycero-phosphocholine (DOPC). This allowed us to elucidate lipid–assembly structure correlations in sonicated formulations with high charge density, which are not accessible with univalent lipids such as the well-studied DOTAP (+1 e ). Cryogenic transmission electron microscopy (cryo-TEM) allowed us to determine the structure of the lipid assemblies, revealing diverse combinations of vesicles and disc-shaped, worm-like, and spherical micelles. Remarkably, MVL5 forms an essentially pure phase of disc micelles at 50 mol % MVL5. At a higher (75 mol %) content of MVL5, short- and intermediate-length worm-like micellar rods were observed, and in ternary mixtures with PEG-lipid, longer and highly flexible worm-like micelles formed. Independent of their length, the worm-like micelles coexisted with spherical micelles. In stark contrast, DOTAP forms mixtures of vesicles, disc micelles, and spherical micelles at all studied compositions, even when combined with PEG-lipids. The observed similarities and differences in the effects of charge (multivalent versus univalent) and high curvature (multivalent charge versus PEG-lipid) on the assembly structure provide insights into parameters that control the size of fluid lipid nanodiscs, relevant for future applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Materials Department, University of California, Santa Barbara, California 93106, United States

Chemistry and Biochemistry Department, University of California, Santa Barbara, California 93106, United States

The National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, New York 10027, United States

Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, California 93106, United States

Physics Department, University of California, Santa Barbara, California 93106, United States

Funding

Division of Graduate Education · National Institute of General Medical Sciences · Simons Foundation · Division of Materials Research

References (82)

Show source-provided references
1. 10.1155/2018/342020410.1155/2018/3420204 ↗
2. 10.1021/cr300061w10.1021/cr300061w ↗
3. 10.1038/nmat376510.1038/nmat3765 ↗
4. 10.3390/pharmaceutics1309136510.3390/pharmaceutics13091365 ↗
5. 10.1016/j.addr.2015.02.00710.1016/j.addr.2015.02.007 ↗
6. 10.1002/jgm.301510.1002/jgm.3015 ↗
7. The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide, 2022 https://a873679.fmphost.com/fmi/webd/GTCT. (accessed June 9, 2022)
8. 10.1038/nrg376310.1038/nrg3763 ↗
9. 10.1007/s40265-018-0983-610.1007/s40265-018-0983-6 ↗
10. 10.1038/s41573-019-0017-410.1038/s41573-019-0017-4 ↗
11. United States Food and Drug Administration Pfizer-Biontech COVID-19 Vaccine Emergency Use Authorization Fact Sheet for Healthcare Providers Administering Vaccine, 2021 https://www.fda.gov/media/144413/download. (accessed June 10, 2021)10.47287/cen-09931-buscon1 ↗
12. Corbett, K. S.; Edwards, D.; Leist, S. R.; Abiona, O. M.; Boyoglu-Barnum, S.; Gillespie, R. A.; Himansu, S.; Schäfer, A.; Ziwawo, C. T.; DiPiazza, A. T.; Dinnon, K. H.; Elbashir, S. M.; Shaw, C. A.; Woods, A.; Fritch, E. J.; Martinez, D. R.; Bock, K. W.; Minai, M.; Nagata, B. M.; Hutchinson, G. B.; Bahl, K.; Garcia-Dominguez, D.; Ma, L.; Renzi, I.; Kong, W.P.; Schmidt, S. D.; Wang, L.; Zhang, Y.; Stevens, L. J.; Phung, E.; Chang, L. A.; Loomis, R. J.; Altaras, N. E.; Narayanan, E.; Metkar, M.; Presnyak, V.; Liu, C.; Louder, M. K.; Shi, W.; Leung, K.; Yang, E. S.; West, A.; Gully, K. L.; Wang, N.; Wrapp, D.; Doria-Rose, N. A.; Stewart-Jones, G.; Bennett, H.; Nason, M. C.; Ruckwardt, T. J.; McLellan, J. S.; Denison, M. R.; Chappell, J. D.; Moore, I. N.; Morabito, K. M.; Mascola, J. R.; Baric, R. S.; Carfi, A.; Graham, B. S. SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness bioRxiv, 2020.10.1101/2020.06.11.145920 ↗
13. 10.1056/NEJMoa203538910.1056/NEJMoa2035389 ↗
14. 10.1056/NEJMoa203457710.1056/NEJMoa2034577 ↗
15. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
16. 10.1016/j.jconrel.2012.06.00210.1016/j.jconrel.2012.06.002 ↗
17. 10.4172/2157-7439.100016410.4172/2157-7439.1000164 ↗
18. 10.1021/jacs.5b0997410.1021/jacs.5b09974 ↗
19. 10.1002/jps.2145810.1002/jps.21458 ↗
20. 10.1023/A:102048801226410.1023/A:1020488012264 ↗
21. 10.1021/nl025604a10.1021/nl025604a ↗
22. 10.1016/0169-409X(95)00032-310.1016/0169-409X(95)00032-3 ↗
23. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
24. 10.1016/j.jconrel.2012.09.00610.1016/j.jconrel.2012.09.006 ↗
25. 10.1002/jps.106310.1002/jps.1063 ↗
26. 10.2147/IJN.S11372310.2147/IJN.S113723 ↗
27. 10.3109/08982104.2014.99567110.3109/08982104.2014.995671 ↗
28. 10.1002/(SICI)1097-4636(199908)46:2<141::AID-JBM2>3.0.CO;2-U10.1002/(SICI)1097-4636(199908)46:2<141::AID-JBM2>3.0.CO;2-U ↗
29. 10.1016/j.biomaterials.2017.08.02610.1016/j.biomaterials.2017.08.026 ↗
30. 10.1038/s41598-021-86484-910.1038/s41598-021-86484-9 ↗
31. 10.1016/j.ajps.2020.07.00510.1016/j.ajps.2020.07.005 ↗
32. 10.1016/j.jconrel.2012.07.01310.1016/j.jconrel.2012.07.013 ↗
33. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
34. 10.1021/acsami.9b1615010.1021/acsami.9b16150 ↗
35. 10.1002/anbr.20210008010.1002/anbr.202100080 ↗
36. 10.1021/acsami.8b2160910.1021/acsami.8b21609 ↗
37. 10.1038/s41563-022-01251-z10.1038/s41563-022-01251-z ↗
38. 10.1021/acsami.2c1796110.1021/acsami.2c17961 ↗
39. 10.1166/jbn.2016.229210.1166/jbn.2016.2292 ↗
40. 10.1021/ja055907h10.1021/ja055907h ↗
41. 10.1021/bc050310c10.1021/bc050310c ↗
42. 10.1021/jp806863z10.1021/jp806863z ↗
43. Campbell R. B. · Cancer Res. · 2002 · 62 · 6831
44. 10.1002/ijc.2484610.1002/ijc.24846 ↗
45. 10.1172/JCI96510.1172/JCI965 ↗
46. 10.3892/or_0000044010.3892/or_00000440 ↗
47. Schmitt-Sody M. · Clin. Cancer Res. · 2003 · 9 · 2335
48. 10.1002/jps.2204310.1002/jps.22043 ↗
49. 10.1016/0169-409X(95)00029-710.1016/0169-409X(95)00029-7 ↗
50. 10.1021/acs.langmuir.5b0279710.1021/acs.langmuir.5b02797 ↗
51. 10.1002/jps.2015010.1002/jps.20150 ↗
52. 10.1021/acsomega.7b0193510.1021/acsomega.7b01935 ↗
53. 10.1016/j.molliq.2019.01.12410.1016/j.molliq.2019.01.124 ↗
54. 10.1002/cnma.20190046810.1002/cnma.201900468 ↗
55. 10.1093/annonc/mdu02510.1093/annonc/mdu025 ↗
56. 10.1021/jm020233w10.1021/jm020233w ↗
57. 10.1529/biophysj.107.12466910.1529/biophysj.107.124669 ↗
58. 10.1021/la802237510.1021/la8022375 ↗
59. 10.1039/c1sm05481c10.1039/c1sm05481c ↗
60. 10.1021/ja105976310.1021/ja1059763 ↗
61. 10.1021/la200679x10.1021/la200679x ↗
62. 10.1021/bi062138l10.1021/bi062138l ↗
63. 10.1002/jgm.71710.1002/jgm.717 ↗
64. 10.1016/S0006-3495(03)74798-510.1016/S0006-3495(03)74798-5 ↗
65. 10.1021/la063501s10.1021/la063501s ↗
66. 10.1021/acs.langmuir.5b0099310.1021/acs.langmuir.5b00993 ↗
67. 10.1016/S0006-3495(95)80369-310.1016/S0006-3495(95)80369-3 ↗
68. 10.1016/S0005-2736(03)00197-410.1016/S0005-2736(03)00197-4 ↗
69. 10.1063/1.45776410.1063/1.457764 ↗
70. 10.1002/cphc.20060069210.1002/cphc.200600692 ↗
71. 10.1039/f2976720152510.1039/f29767201525 ↗
72. Israelachvili J. N. · 2011
73. 10.1515/znc-1973-11-120910.1515/znc-1973-11-1209 ↗
74. Lipowsky R. · 1995 · 1
75. 10.1126/science.275.5301.81010.1126/science.275.5301.810 ↗
76. 10.1016/j.biomaterials.2014.03.00710.1016/j.biomaterials.2014.03.007 ↗
77. 10.1016/S0006-3495(94)80938-510.1016/S0006-3495(94)80938-5 ↗
78. 10.1016/0005-2736(92)90112-Y10.1016/0005-2736(92)90112-Y ↗
79. 10.1016/j.bbamem.2011.04.02010.1016/j.bbamem.2011.04.020 ↗
80. 10.1016/j.bmcl.2016.01.07910.1016/j.bmcl.2016.01.079 ↗
81. 10.1093/oxfordjournals.jmicro.a04947210.1093/oxfordjournals.jmicro.a049472 ↗
82. 10.1016/j.jsb.2005.03.01010.1016/j.jsb.2005.03.010 ↗